| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Hansa Biopharma to Host Conference Call to Provide Interim Results for the First Half of 2020 and Business Update
By: PR Newswire Association LLC. - 30 Jun 2020Back to overview list

LUND, Sweden, June 30, 2020 /PRNewswire/ -- Hansa Biopharma will publish its interim report for January-June 2020 at 8:00 a.m. CET on July 16, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 2:00 p.m. CET. The event will be hosted by Hansa Biopharma's CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.

Slides used in the presentation will be live on the company website during the call under "Events & Webcast," and will also be made available online after the call. 

To participate in the telephone conference, please use the dial-in details provided below:

Dial-in numbers for participants:

SE: +46 8 56 64 27 07
UK: +44 333 300 92 65
US: +1 833 249 84 07

The webcast will be available on

For further information, please contact:

Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269

This information was brought to you by Cision,c3144212

The following files are available for download:

Cision View original content:

SOURCE Hansa Biopharma AB

Related companies:Hansa Biopharma AB
Copyright 2020 PR Newswire Association LLC. Back to overview list
to the top ↑